Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. Keeping that in mind, here are three low-volatility stocks that don’t make the cut and some better opportunities instead. Bright Horizons (BFAM) Rolling One-Year Beta: 0.38 Founded in 1986, Bright Horizons (NYSE:BFAM) is a global provider of child care, early education, and workforce support solutions. Why Do We Avoid BFAM? Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth Incremental sales over the last five years were less profitable as its earnings per share were flat while its revenue grew Below-average returns on capital indicate management struggled to find compelling investment opportunities Bright Horizons is trading at $122.32 per share, or 29.4x forward P/E. To fully understand why you should be careful with BFAM, check out our full research report (it’s free). General Motors (GM) Rolling One-Year Beta: 0.78 Founded in 1908 by William C. Durant, General Motors (NYSE:GM) offers a range of vehicles and automobiles through brands such as Chevrolet, Buick, GMC, and Cadillac. Why Is GM Not Exciting? Disappointing unit sales over the past two years suggest it might have to lower prices to accelerate growth Estimated sales decline of 6.2% for the next 12 months implies a challenging demand environment Gross margin of 12.5% is below its competitors, leaving less money to invest in areas like marketing and R&D General Motors’s stock price of $49.68 implies a valuation ratio of 4.6x forward P/E. If you’re considering GM for your portfolio, see our FREE research report to learn more. Select Medical (SEM) Rolling One-Year Beta: 0.64 With a nationwide network spanning 46 states and over 2,700 healthcare facilities, Select Medical (NYSE:SEM) operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers across the United States. Why Is SEM Risky? Declining admissions over the past two years indicate demand is soft and that the company may need to revise its strategy Projected sales decline of 11.6% over the next 12 months indicates demand will continue deteriorating Free cash flow margin dropped by 13.2 percentage points over the last five years, implying the company became more capital intensive as competition picked up Story Continues At $15.23 per share, Select Medical trades at 13x forward P/E. Check out our free in-depth research report to learn more about why SEM doesn’t pass our bar. Stocks We Like More The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. View Comments
3 Low-Volatility Stocks in Hot Water
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...